Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
| ▸ | TDO2 | P48775 | 1/20 | 0.30 |
| ▸ | NSD2 | O96028 | 1/20 | 0.30 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1374667 | 1.00 | IDO1 (0.30) | IDO1TDO2NSD2DNMT1 | |
| SCHEMBL27427848 | 0.77 | — | — | |
| SCHEMBL25438002 | 0.74 | — | — | |
| SCHEMBL11893672 | 0.74 | NPC1 (0.34) | — | |
| SCHEMBL1905316 | 0.73 | — | — | |
| SCHEMBL22899552 | 0.72 | TP53 (0.30) | — | |
| SCHEMBL18401355 | 0.71 | IDO1 (0.30) | IDO1TDO2NSD2DNMT1 | |
| SCHEMBL19242264 | 0.71 | — | — | |
| SCHEMBL25514211 | 0.71 | — | — | |
| SCHEMBL19910349 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2392578-B1 | CYCLOOCTATETRAENETRICARBONYLRUTHENIUM COMPLEX, PROCESS FOR PRODUCING SAME, AND PROCESS FOR PRODUCING FILM USING THE COMPLEX AS RAW MATERIAL | TANAKA PRECIOUS METAL IND (JP) | 2017-11-29 | — | — | EP | disclosed |
| US-8920875-B2 | Cyclooctatetraenetricarbonyl ruthenium complex, method of producing the same, and method of producing film using the complex as raw material | TANAKA KIKINZOKU KOGYO K.K. (JP) | 2014-12-30 | — | — | US | disclosed |
| EP-2392578-A1 | CYCLOOCTATETRAENETRICARBONYLRUTHENIUM COMPLEX, PROCESS FOR PRODUCING SAME, AND PROCESS FOR PRODUCING FILM USING THE COMPLEX AS RAW MATERIAL | Tanaka Kikinzoku Kogyo K.K. (JP) | 2011-12-07 | — | — | EP | disclosed |
| US-20110287175-A1 | CYCLOOCTATETRAENETRICARBONYL RUTHENIUM COMPLEX, METHOD OF PRODUCING THE SAME, AND METHOD OF PRODUCING FILM USING THE COMPLEX AS RAW MATERIAL | TANAKA KIKINZOKU KOGYO K.K. (JP) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110287175-A1 | CYCLOOCTATETRAENETRICARBONYL RUTHENIUM COMPLEX, METHOD OF PRODUCING THE SAME, AND METHOD OF PRODUCING FILM USING THE COMPLEX AS RAW MATERIAL | C9, RNF168, C5 | IDO1 3403/4885TDO2 68/4885NSD2 3890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.